Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy

18 Nov 2017

Abstract excerpt

// Francesca Scionti 1, * , Maria Teresa Di Martino 1, * , Simona Sestito 2 , Angela Nicoletti 2 , Francesca Falvo 2 , Katia Roppa 2 , Mariamena Arbitrio 3 , Pietro Hiram Guzzi 4 , Giuseppe Agapito 4 , Antonio Pisani 5 , Eleonora Riccio 5 , Daniela Concolino 2, # and Licia Pensabene 2, # 1 Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research and Pathophysiology
Share to Glycogen Storage Diseases and Myoclonus
Share to Lysosomal Storage Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29296186
DOI: 10.18632/oncotarget.22505

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants associated with Fabry disease progression despite enzyme replacement therapyPMID 29296186Read ↗

Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry diseaseSemantic proximity Read ↗

Fabry disease: Mechanism and therapeutics strategiesSemantic proximity Read ↗

Diagnosis and Management of Fabry Disease in High-Risk Renal Disease Patients in Taiwan: A Single Center Study.Semantic proximity Read ↗

Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.Semantic proximity Read ↗

Fabry disease and enzyme replacement therapy in classic patients with same mutation: different formulations--different outcome?Semantic proximity Read ↗

Novel <em>GLA</em> Variants: 10 Experts’ Tips for the Clinical Assessment of Fabry DiseaseSemantic proximity Read ↗

Genetic variants associated with gastrointestinal symptoms in Fabry disease.Semantic proximity Read ↗

FABRY DISEASE: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat. What Do We Know Today?Semantic proximity Read ↗

Pathomechanisms of renal Fabry diseaseSemantic proximity Read ↗

Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposingSemantic proximity Read ↗

Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome SurveySemantic proximity Read ↗

Fabry disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac, and stroke clinicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.